Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Indicadores sociales
2
Administración
1
Antropología forense
1
Calidad de vida
1
Capital humano
1
Comportamiento organizacional
1
Comunidades indígenas
1
Condiciones sociales
1
Desarrollo sostenible
1
Educación inclusiva
1
Educación superior
1
Estudiantes con discapacidades
1
Exhumación
1
Filosofía de la tecnología
1
Identificación
1
Liderazgo
1
Minorías
1
Muerte
1
Mujeres
1
Personas desaparecidas
1
Realidad virtual
1
-
3881por Klement, Rainer J., Popp, Ilinca, Kaul, David, Ehret, Felix, Grosu, Anca L., Polat, Bülent, Sweeney, Reinhart A., Lewitzki, Victor“…In multivariable frailty regression, better performance status, gross-total versus not gross-total resection, MGMT hypermethylation, IDH mutation, smaller planning target volume and salvage therapy were significantly associated with longer OS (all p < 0.01). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3882por Yang, Keyang, Wu, Zhijing, Zhang, Hao, Zhang, Nan, Wu, Wantao, Wang, Zeyu, Dai, Ziyu, Zhang, Xun, Zhang, Liyang, Peng, Yun, Ye, Weijie, Zeng, Wenjing, Liu, Zhixiong, Cheng, Quan“…Here, we discuss novel feasible or potential targets for treatment of gliomas, especially IDH-wild type glioblastoma. Classic targets such as the p53 and retinoblastoma (RB) pathway and epidermal growth factor receptor (EGFR) gene alteration have met failure due to complex regulatory network. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3883“…A total of 18 hub genes (HMGCS1, SQLE, ESR1, LAMC1, HOXB4, PIP5K1B, GNG11, GPX3, PAX2, TF, ALDH6A1, IDH1, SALL1, EYA1, TAGLN, TPD52L1, ST6GALNAC1, NNMT) were identified. 10 of the 18 hub genes were significantly differentially expressed in RIF patients as validated by GSE111974. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3884por Hernández-López, Reyniel, Torrens-Mas, Margalida, Pons, Daniel G., Company, Maria M., Falcó, Esther, Fernández, Teresa, Ibarra de la Rosa, Javier M., Roca, Pilar, Oliver, Jordi, Sastre-Serra, Jorge“…Notable differences in the protein expression levels of ATPase, IDH2, LDHA, and SIRT1, as well as mtDNA amount, were detected between the samples of non-tumor adjacent tissue and tumor tissue from metastatic CRC patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3885por Hauffe, Laura, Picard, Daniel, Musa, Julian, Remke, Marc, Grünewald, Thomas G. P., Rotblat, Barak, Reifenberger, Guido, Leprivier, Gabriel“…We verified that EIF4EBP1 mRNA is overexpressed in malignant gliomas, including isocitrate dehydrogenase (IDH)-wildtype glioblastomas, relative to non-neoplastic brain tissue in multiple publically available datasets. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3886por Rao, Changjun, Jin, Jinghao, Lu, Jianglong, Wang, Chengde, Wu, Zerui, Zhu, Zhangzhang, Tu, Ming, Su, Zhipeng, Li, Qun“…A final nomogram was developed using factors associated with prognosis, including age, sex, the extent of tumor resection, IDH mutation status, radiotherapy status, chemotherapy status, and risk. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3887por Gao, Lei, Wu, Jia, Wang, Hai, Yang, Yongyu, Zheng, Zongliao, Ni, Bowen, Wang, Xiran, Peng, Yuping, Li, Yaomin“…High levels of LMO1 mRNA were correlated with poor prognosis in patients with isocitrate dehydrogenase (IDH)-wild-type (wt) and 1p/19q non-codeletion gliomas. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3888por Jawad, Majd, Afkhami, Michelle, Ding, Yi, Zhang, Xiaohui, Li, Peng, Young, Kim, Xu, Mina Luqing, Cui, Wei, Zhao, Yiqing, Halene, Stephanie, Al-Kali, Aref, Viswanatha, David, Chen, Dong, He, Rong, Zheng, Gang“…Next with the largest cohort of patients with DNMT3A R882 mutant MDS known to date from multiple institutions, DNMT3A R882 mutant MDS cases were shown to have more severe leukopenia, enriched SRSF2 and IDH2 mutations, increased cases with excess blasts (47% vs 22.5%, p=.004), markedly increased risk of AML transformation (25.8%, vs. 1.7%, p=.0001) and a worse progression-free survival (PFS) (median 20.3, vs. >50 months, p=.009) than non-R882 mutant MDS cases. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3889por Wu, Xuechao, Wan, Quan, Wang, Jing, Hou, Peng, Zhang, Qijian, Wang, Qing, Lu, Xiaojie“…RESULTS: MIR155HG was predominantly expressed in the isocitrate dehydrogenase (IDH) wild-type as well as mesenchymal subtype gliomas. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3890por Jiang, Xiulin, Shi, Yulin, Chen, Xi, Xu, Haitao, Huang, Xiaobin, Li, Lihua, Pu, Jun“…Our results demonstrated that BIRC5 was highly expressed in LGG and the expression level correlated with tumor grade, prognosis, histological subtype, isocitrate dehydrogenase 1 (IDH1) mutation, 1p/19q chromosomal co-deletion, chemotherapy status, and O[6]-methylguanine-DNA methyltransferase (MGMT) promoter methylation status. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3891por Zhang, Jiheng, Wang, Nan, Wu, Jiasheng, Gao, Xin, Zhao, Hongtao, Liu, Zhihui, Yan, Xiuwei, Dong, Jiawei, Wang, Fang, Ba, Yixu, Ma, Shuai, Jin, Jiaqi, Du, Jianyang, Ji, Hang, Hu, Shaoshan“…Notably, mutation rate, WHO class II, IDH mutation, 1p/19q co-deletion and MGMT promoter methylation were increased in the low m5CrLS score group. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3892por Tirrò, Elena, Massimino, Michele, Broggi, Giuseppe, Romano, Chiara, Minasi, Simone, Gianno, Francesca, Antonelli, Manila, Motta, Gianmarco, Certo, Francesco, Altieri, Roberto, Manzella, Livia, Caltabiano, Rosario, Barbagallo, Giuseppe Maria Vincenzo, Buttarelli, Francesca Romana, Magro, Gaetano, Giangaspero, Felice, Vigneri, Paolo“…Specifically, the Glio-DNA panel targets specific genetic and chromosomal alterations involving ATRX chromatin remodeler (ATRX), cyclin dependent kinase inhibitor 2A (CDKN2A), isocitrate dehydrogenase (NADP+) 1 (IDH1) and the telomerase reverse transcriptase (TERT) promoter while also recognizing the co-deletion of 1p/19q, loss of chromosome 10 and gain of chromosome 7. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3893por Joseph, Justin V, Magaut, Capucine R, Storevik, Simon, Geraldo, Luiz H, Mathivet, Thomas, Latif, Md Abdul, Rudewicz, Justine, Guyon, Joris, Gambaretti, Matteo, Haukas, Frida, Trones, Amalie, Rømo Ystaas, Lars A, Hossain, Jubayer A, Ninzima, Sandra, Cuvellier, Sylvain, Zhou, Wenjing, Tomar, Tushar, Klink, Barbara, Rane, Lalit, Irving, Bronwyn K, Marrison, Joanne, O’Toole, Peter, Wurdak, Heiko, Wang, Jian, Di, Zhang, Birkeland, Even, Berven, Frode S, Winkler, Frank, Kruyt, Frank A E, Bikfalvi, Andreas, Bjerkvig, Rolf, Daubon, Thomas, Miletic, Hrvoje“…MTs are abundant in chemoresistant gliomas, in particular, glioblastomas (GBMs), while they are uncommon in chemosensitive IDH-mutant and 1p/19q co-deleted oligodendrogliomas. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3894por Ramesh, Karthik, Mellon, Eric A, Gurbani, Saumya S, Weinberg, Brent D, Schreibmann, Eduard, Sheriff, Sulaiman A, Goryawala, Mohammed, de le Fuente, Macarena, Eaton, Bree R, Zhong, Jim, Voloschin, Alfredo D, Sengupta, Soma, Dunbar, Erin M, Holdhoff, Matthias, Barker, Peter B, Maudsley, Andrew A, Kleinberg, Lawrence R, Shim, Hyunsuk, Shu, Hui-Kuo G“…The median age was 59 years. 30% were MGMT promoter hypermethylated; 7% harbored IDH1 mutation. With a median follow-up of 21.4 months for censored patients, median overall survival (OS) and progression-free survival were 23.0 and 16.6 months, respectively. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3895por Lin, Minhua, Huang, Tianxiang, Wang, Xuan, Li, Xuenan, Ma, Jingjiao, Su, Lan, Wu, Jun“…On the another hand, LGG in non-canonical NF-κB-high group showed high frequency of EGFR mutations but relatively low frequency of IDH mutations. In addition, LGG in this group reflected immunosuppressive environment characterized by high level of cytotoxic T cell exhaustion and macrophage M2 infiltration. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3896“…Data from recent large-scale exome analyses have revealed the heterogeneity in the molecular profiles of iCCA, showing that small duct type iCCA exhibit frequent BAP1, IDH1/2 hotspot mutations and FGFR2 fusion, in contrast to frequent mutations in KRAS, TP53, and SMAD4 observed in large duct type iCCA. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3897
-
3898
-
3899por Martínez-García, María, Velasco, Guillermo, Pineda, Estela, Gil-Gil, Miguel, Alameda, Francesc, Capellades, Jaume, Martín-Soberón, Mari Cruz, López-Valero, Israel, Tovar Ambel, Elena, Foro, Palmira, Taus, Álvaro, Arumi, Montserrat, Hernández-Laín, Aurelio, Sepúlveda-Sánchez, Juan Manuel“…The median age was 52 years (33–76), 44% were male, 44% were MGMT methylated, and three patients had IDH1/2 mutation. In DE, DLTs were reported in 1/6 in the second cohort (250 mg/QD), declaring 250 mg/QD of crizotinib as the RP2D for the EC. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3900por Omura, Takaki, Takahashi, Masamichi, Ohno, Makoto, Miyakita, Yasuji, Yanagisawa, Shunsuke, Tamura, Yukie, Kikuchi, Miyu, Kawauchi, Daisuke, Nakano, Tomoyuki, Hosoya, Tomohiro, Igaki, Hiroshi, Satomi, Kaishi, Yoshida, Akihiko, Sunami, Kuniko, Hirata, Makoto, Shimoi, Tatsunori, Sudo, Kazuki, Okuma, Hitomi S., Yonemori, Kan, Suzuki, Hiromichi, Ichimura, Koichi, Narita, Yoshitaka“…A total of 49 patients with IDH-wildtype glioblastoma showed frequent genomic aberrations in the following genes: TERT promoter (67%), CDKN2A (57%), CDKN2B (51%), MTAP (41%), TP53 (35%), EGFR (31%), PTEN (31%), NF1 (18%), BRAF (12%), PDGFRA (12%), CDK4 (10%), and PIK3CA (10%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto